Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.42 |
| ▸ | FURIN | P09958 | 2/20 | 0.39 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 7/20 | 0.38 |
| ▸ | SIRT1 | Q96EB6 | 6/20 | 0.38 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.38 |
| ▸ | MAP1LC3B | Q9GZQ8 | 1/20 | 0.37 |
| ▸ | TLR2 | O60603 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30361583 | 0.93 | PTPN1 (0.43) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL22442662 | 0.93 | PTPN1 (0.43) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL22442664 | 0.93 | PTPN1 (0.43) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL30288542 | 0.93 | PTPN1 (0.42) | PTPN1FURINSSTR3MAP1LC3B | |
| SCHEMBL12094377 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL13830646 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL12944195 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL2734925 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL19731720 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 | |
| SCHEMBL29579452 | 0.92 | HTR2A (0.40) | PTPN1FURINSSTR3SIRT2SIRT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023129518-A1 | TUBULYSINS AND PROTEIN-TUBULYSIN CONJUGATES | REGENERON PHARMACEUTICALS, INC. (US) | 2023-07-06 | — | — | WO | disclosed |